Severe SARS-CoV-2 Pneumonia and Pneumomediastinum/Pneumothorax: A Prospective Observational Study in an Intermediate Respiratory Care Unit.
Miguel Lorente-GonzálezJosé Rafael Terán-TinedoAnnette Zevallos-VillegasDaniel LaordenPablo Mariscal-AguilarMiguel Suárez-OrtizEduardo Cano-SanzMaría Ángeles Ortega-FraileJoaquín Hernández NúñezAdalgisa FalconeElena María Saiz-LouMaría Cristina Plaza-MorenoChristian García-FadulManuel Valle-FalconesAna Sánchez-AzofraClotilde Funes-MorenoIsabel De-La-Calle-GilRosalía Navarro-CasadoDaniel Carballo-LópezSoraya Gholamian-OvejeroBerta Gallego-RodríguezTomás Villén-VillegasPedro LandetePublished in: Journal of intensive care medicine (2023)
In patients admitted to the IRCU for severe SARS-CoV-2 pneumonia requiring NIRS, incidences of PM/PTX, PM, PTX, and PM + PTX were observed to be 4.3%, 3.8%, 1.6%, and 1.1%, respectively. Most patients with PM/PTX had HFNC + CPAP/BiPAP as the NIRS device, much more frequently than patients without PM and PTX. The probabilities of IMV and death among patients with PM/PTX were 64.3% and 33.9%, respectively, higher than those observed in patients without PM and PTX, which were 21.0% and 10.5%, respectively.
Keyphrases
- particulate matter
- air pollution
- sars cov
- polycyclic aromatic hydrocarbons
- end stage renal disease
- heavy metals
- water soluble
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- healthcare
- obstructive sleep apnea
- prognostic factors
- patient reported outcomes
- quality improvement
- early onset
- coronavirus disease
- intensive care unit
- extracorporeal membrane oxygenation
- chronic pain